Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|16|20|2184-2193
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.16, Iss.20, 2010-07, pp. : 2184-2193
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Basal cell carcinoma: a paradigm for targeted therapies
By Dreier Jil
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
Access to resources
Recommend
ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
Current Medicinal Chemistry, Vol. 23, Iss. 2, 2016-01 ,pp. :
Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. :
Pharmacogenetics in Oncology: A Promising Field
Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. :